Kiss, A.; Ráduly, A.P.; Regdon, Z.; Polgár, Z.; Tarapcsák, S.; Sturniolo, I.; El‐Hamoly, T.; Virág, L.; Hegedűs, C.
Targeting Nuclear NAD+ Synthesis Inhibits DNA Repair, Impairs Metabolic Adaptation and Increases Chemosensitivity of U-2OS Osteosarcoma Cells. Cancers 2020, 12, 1180.
https://doi.org/10.3390/cancers12051180
AMA Style
Kiss A, Ráduly AP, Regdon Z, Polgár Z, Tarapcsák S, Sturniolo I, El‐Hamoly T, Virág L, Hegedűs C.
Targeting Nuclear NAD+ Synthesis Inhibits DNA Repair, Impairs Metabolic Adaptation and Increases Chemosensitivity of U-2OS Osteosarcoma Cells. Cancers. 2020; 12(5):1180.
https://doi.org/10.3390/cancers12051180
Chicago/Turabian Style
Kiss, Alexandra, Arnold Péter Ráduly, Zsolt Regdon, Zsuzsanna Polgár, Szabolcs Tarapcsák, Isotta Sturniolo, Tarek El‐Hamoly, László Virág, and Csaba Hegedűs.
2020. "Targeting Nuclear NAD+ Synthesis Inhibits DNA Repair, Impairs Metabolic Adaptation and Increases Chemosensitivity of U-2OS Osteosarcoma Cells" Cancers 12, no. 5: 1180.
https://doi.org/10.3390/cancers12051180
APA Style
Kiss, A., Ráduly, A. P., Regdon, Z., Polgár, Z., Tarapcsák, S., Sturniolo, I., El‐Hamoly, T., Virág, L., & Hegedűs, C.
(2020). Targeting Nuclear NAD+ Synthesis Inhibits DNA Repair, Impairs Metabolic Adaptation and Increases Chemosensitivity of U-2OS Osteosarcoma Cells. Cancers, 12(5), 1180.
https://doi.org/10.3390/cancers12051180